A STRUCTURE-FUNCTION RELATIONSHIP AMONG RESERPINE AND YOHIMBINE ANALOGS IN THEIR ABILITY TO INCREASE EXPRESSION OF MDR1 AND P-GLYCOPROTEIN IN A HUMAN COLON-CARCINOMA CELL-LINE
Ug. Bhat et al., A STRUCTURE-FUNCTION RELATIONSHIP AMONG RESERPINE AND YOHIMBINE ANALOGS IN THEIR ABILITY TO INCREASE EXPRESSION OF MDR1 AND P-GLYCOPROTEIN IN A HUMAN COLON-CARCINOMA CELL-LINE, Molecular pharmacology, 48(4), 1995, pp. 682-689
We previously showed that there is a structure-function relationship a
mong reserpine and yohimbine analogues in their ability to inhibit the
function of P-glycoprotein (P-gp) and reverse multidrug resistance (M
DR). Because some P-gp inhibitors (e.g., verapamil and nifedipine) can
increase mdr1 and P-gp expression in human colon carcinoma cell lines
, we used our reserpine/yohimbine analogues to determine whether there
was a structural requirement for this induction. We found that 10 mu
M reserpine increased both mdr1 and P-gp expression by 4-10-fold in 48
hr in a human colon carcinoma cell line that expresses moderate level
s of mdr1 (LS180-Ad50) but not in several other cell lines that expres
sed no mdr1. The reserpine/yohimbine analogues rescinnamine, trimethox
ybenzoylyohimbine, and LY191401 (compound G), all of which contain the
three structural elements used to describe the MDR pharmacophore, als
o increased both mdr1 and P-gp expression significantly. Despite some
exceptions, we found that there was a good association between the abi
lity of these analogues to induce mdr1 and P-gp expression and their a
bility to reverse vinblastine and doxorubicin resistance, revealing a
structure-function relationship for this phenomenon. The increased P-g
p expressed by these cells appeared to be functional, as determined by
flow cytometric detection of rhodamine 123 retention. The increased e
xpression was suppressed by 5,6-dichloro-1-beta-D-ribofuranosylbenzimi
dazole, an RNA synthesis inhibitor, whereas the protein synthesis inhi
bitor cycloheximide enhanced the expression several-fold, suggesting t
hat induction of mdr1 by these analogues is regulated at both the tran
scriptional and post-transcriptional levels. Given that the effect is
seen only in cell lines that express some P-gp and is mediated only by
active, P-gp-interacting compounds, we speculate that induction of md
r1 and P-gp by these agents may be mediated through a feedback mechani
sm.